Correction to: Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology

Affiliations

¹ Centre for Neuroimaging Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College, London, UK. tricklebank.mark@kcl.ac.uk.
² Department of Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, CB23EB, UK.
³ Centre for Neuroimaging Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College, London, UK.
⁴ Department of Psychiatry, University of British Columbia, Vancouver, Canada.

Published Erratum

Mark David Tricklebank et al. Psychopharmacology (Berl). 2021 Jul.

. 2021 Jul;238(7):2045.

doi: 10.1007/s00213-021-05859-y.

¹ Centre for Neuroimaging Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College, London, UK. tricklebank.mark@kcl.ac.uk.
² Department of Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, CB23EB, UK.
³ Centre for Neuroimaging Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College, London, UK.
⁴ Department of Psychiatry, University of British Columbia, Vancouver, Canada.

No abstract available

Erratum for

Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.
Tricklebank MD, Robbins TW, Simmons C, Wong EHF. Tricklebank MD, et al. Psychopharmacology (Berl). 2021 Jun;238(6):1417-1436. doi: 10.1007/s00213-021-05787-x. Epub 2021 Mar 10. Psychopharmacology (Berl). 2021. PMID: 33694032 Free PMC article. Review.